The Female Health Company Added to Russell 2000(R) Index

CHICAGO, June 30  /PRNewswire-FirstCall/ -- The Female Health Company (NASDAQ:FHCO) today announced that it has been added to the Russell 2000(R) Index after the Russell Investment Group reconstituted its comprehensive set of U.S. and global equity indexes on June 26th, 2009.

The Russell 2000(R) Index is comprised of companies 1001 through 3000 within the Russell 3000, and is generally viewed as the benchmark for small cap companies.  "We are very pleased to learn that The Female Health Company has qualified for inclusion in the Russell 2000(R) Index and believe that this reflects our Company's continued positive momentum," stated O.B. Parrish, Chief Executive Officer of The Female Health Company.  "Membership in the Russell 2000(R) Index is based upon market capitalizations of qualifying companies, and The Female Health Company's 'market cap' has increased from approximately $72 million at the end of June 2008 to approximately $107 million at the May 29, 2009 measurement date.  Russell is an industry leader for stock indexes, and we expect our inclusion in the Russell 2000(R) Index to generate greater interest in our stock among institutional investors."

The Russell family of U.S. indexes is designed to be a comprehensive representation of the investable U.S. equity market.  These indexes are value-weighted and include only common stocks belonging to corporations that are incorporated in the United States and its territories.  Final membership lists for the Russell 3000(R), Russell 1000(R), Russell 2000(R), Russell Global, Russell Midcap(R) and Russell Microcap(R) indexes were posted to the Russell Investments website on June 29, 2009.

Real-time market analysis on the Russell indexes is available at http://www.russell.com/indexes/performance/real_time_market_analysis.asp.

About Russell Investments

Russell Investments aims to improve financial security for people by providing strategic advice, world-class implementation, state-of-the-art performance benchmarks, and a range of institutional-quality investment products.  With more than $200 billion in assets under management, Russell serves individual, institutional and advisor clients in more than 40 countries.  Russell provides access to some of the world's best money managers.  It helps investors put this access to work in corporate defined benefit and defined contribution plans, and in the life savings of individual investors.  Russell's indexes are unmanaged and cannot be invested in directly.  Headquartered in Tacoma, Washington, Russell has principal offices in Amsterdam, Auckland, Johannesburg, London, Melbourne, New York, Paris, San Francisco, Seoul, Singapore, Sydney, Tokyo and Toronto.

About The Female Health Company

The Female Health Company (FHC), headquartered in Chicago, IL, is the maker of the FC Female Condom (FC1 and FC2), a revolutionary option offering women dual protection against both sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy.  FHC was created as a worldwide company in February 1996 with the purchase of Chartex Resources Ltd., the holder of exclusive worldwide rights to FC1.  The Company holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People's Republic of China, South Korea and Japan.  FC2 patents have been granted in Australia and South Africa and are pending in various other countries.  FHC is the sole manufacturer and marketer of the FC1 and FC2 female condoms in the world.  The Female Health Company and its partners currently market the Female Condom under FCFemale Condom(R), FC2 Female Condom(R), Reality(R), Femidom(R), Femy(R), and Care(R).

"Safe Harbor" statement under the Private Securities Litigation Reform Action of 1995:

The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings.  Actual events affecting the Company and the impact of such events on the Company's operations may vary from those currently anticipated. 

DATASOURCE: The Female Health Company



CONTACT:  Investors, William R. Gargiulo, Jr., [phone], or Donna

Felch, [phone], both for The Female Health Company



Web Site:  http://www.femalehealth.com/ 

Copyright